Dnaprint Genomics Stock Today
PerformanceVery Weak
| Odds Of DistressVery High
|
DNAPrint Genomics has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of April 2025 and ending today, the 19th of July 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany. DNAPRINT GENOMICS is traded on OTC Exchange in the United States.. More on DNAPrint Genomics
DNAPrint Genomics cannot be verified against its exchange. It appears that DNAPrint Genomics is not available for investing at the moment. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshDNAPrint Stock Highlights
DNAPrint Genomics (DNAG) is traded on OTCCE Exchange in USA and employs 24 people. DNAPrint Genomics is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 386.76 K. DNAPrint Genomics conducts business under Biotechnology sector and is part of Health Care industry.
DNAPrint Genomics currently holds about 134.35 K in cash with (5.78 M) of positive cash flow from operations.
Check DNAPrint Genomics Probability Of Bankruptcy
DNAPrint Stock Against Markets
Try Other Suggestions
DNAPrint Genomics Corporate Management
| FRCPC MD | Ex Officer | Profile | |
| Hector Ruiz | Ex Officer | Profile | |
| Zach Gaskin | Ex Officer | Profile | |
| Shannon Boyd | Ex Officer | Profile | |
| Jatin Patel | Ex Officer | Profile | |
| Lisa Herren | Ex Officer | Profile | |
| Pauline Gula | Ex Officer | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DNAPrint Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in DNAPrint Stock please use our How to Invest in DNAPrint Genomics guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DNAPrint Genomics. If investors know DNAPrint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DNAPrint Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of DNAPrint Genomics is measured differently than its book value, which is the value of DNAPrint that is recorded on the company's balance sheet. Investors also form their own opinion of DNAPrint Genomics' value that differs from its market value or its book value, called intrinsic value, which is DNAPrint Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DNAPrint Genomics' market value can be influenced by many factors that don't directly affect DNAPrint Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DNAPrint Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if DNAPrint Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DNAPrint Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.